Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway-Reference-Cited by-同舟云学术

Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway

Published:2016-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ohtsuka Tomoaki,Sakaguchi Masakiyo,Yamamoto Hiromasa,Tomida Shuta,Takata Katsuyoshi,Shien Kazuhiko,Hashida Shinsuke,Miyata-Takata Tomoko,Watanabe Mototsugu,Suzawa Ken,Soh Junichi,Youyi Chen,Sato Hiroki,Namba Kei,Torigoe Hidejiro,Tsukuda Kazunori,Yoshino Tadashi,Miyoshi Shinichiro,Toyooka Shinichi

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep39557.pdf

Reference41 articles.

1. Kern, J. A. et al. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 50, 5184–5187 (1990).

2. Hsieh, C. C. et al. Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung. Ann Thorac Surg 66, 1159–1163; discussion 1163-1154 (1998).

3. Nakamura, H. et al. Correlation between encoded protein overexpression and copy number of the HER2 gene with survival in non-small cell lung cancer. Int J Cancer 103, 61–66 (2003).

4. Goel, A. & Janknecht, R. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol Cell Biol 23, 6243–6254 (2003).

5. Stephens, P. et al. Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature 431, 525–526 (2004).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced anti-tumor effects by combination of tucatinib and radiation in HER2-overexpressing human cancer cell lines;Cancer Cell International;2024-08-06

2. Enhanced Anti-Tumor Effects by Combination of Tucatinib and Radiation in HER2-Overexpressing Human Cancer Cell Lines;2024-04-09

3. DNA methylation‐associated allelic inactivation regulates Keratin 19 gene expression during pancreatic development and carcinogenesis;The Journal of Pathology;2023-08-09

4. Subcellular localization of hTERT in breast cancer: insights into its tumorigenesis and drug resistance mechanisms in HER2-immunopositive breast cancer;Human Pathology;2023-04

5. Syndecan-4 regulates the HER2-positive breast cancer cell proliferation cells via CK19/AKT signalling;Biochimie;2023-04